bl-4162a and Leukemia--Hairy-Cell

bl-4162a has been researched along with Leukemia--Hairy-Cell* in 1 studies

Reviews

1 review(s) available for bl-4162a and Leukemia--Hairy-Cell

Article	Year
Letting post-marketing bridge the evidence gap: the case of orphan drugs. BMJ (Clinical research ed.), 2016, Jun-22, Volume: 353 Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Barrett Esophagus; Cladribine; Dihematoporphyrin Ether; Ductus Arteriosus, Patent; Hepatolenticular Degeneration; Humans; Ibuprofen; Leukemia, Hairy Cell; Mitotane; Orphan Drug Production; Platelet Aggregation Inhibitors; Product Surveillance, Postmarketing; Quinazolines; Thrombocythemia, Essential; Zinc Acetate	2016

Article

Year

Letting post-marketing bridge the evidence gap: the case of orphan drugs.

BMJ (Clinical research ed.), 2016, Jun-22, Volume: 353

Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Barrett Esophagus; Cladribine; Dihematoporphyrin Ether; Ductus Arteriosus, Patent; Hepatolenticular Degeneration; Humans; Ibuprofen; Leukemia, Hairy Cell; Mitotane; Orphan Drug Production; Platelet Aggregation Inhibitors; Product Surveillance, Postmarketing; Quinazolines; Thrombocythemia, Essential; Zinc Acetate

2016